Germ cells ensure the diversification and totipotency of genetic information via the elaborate genetic and epigenetic regulation of the genome architecture during their development. To understand the mechanism underlying the regulation of genome function in germ cells, it is of primary importance to develop systems in which gene function can be regulated at desired time points during their development. Here, we report the generation of transgenic strains that express Cre recombinase flanked by the ligand-binding domains of murine estrogen receptor (MER Cre MER [MCM]) under the control of the regulatory elements of the Dppa3 (also known as Stella or Pgc7) gene. On the administration of 4-hydroxytamoxifen (4-OHT), the Dppa3-MCM strains recombined the sequence flanked by the loxP elements (the floxed sequence) specifically in primordial germ cells as early as Embryonic Day (E) 7.0, and this recombination became robust after E9.5. Furthermore, these strains exhibited efficient and specific recombination of the floxed sequence during the growth of oocytes and in preimplantation embryos in the 4-OHT-dependent manner. Thus, these Dppa3-MCM strains offer valuable opportunities to explore gene function in both loss-of-function and gain-of-function experiments at a variety of time points during germ cell development.
INTRODUCTION
Germ cells ensure the perpetuation of genetic and epigenetic information across generations because of their ability to form new individual organisms. Understanding the mechanisms underlying the development of the germ cell lineage provides fundamental information about the regulation of genome function in totipotency. In the mouse, the first population of cells that constitute the germline arises as primordial germ cells (PGCs), approximately 40 in number, at around Embryonic Day (E) 7.25 in the extraembryonic mesoderm at the base of the incipient allantois [1] . PGCs start to migrate, one by one, toward the visceral endoderm at around E7.5, move through the developing hindgut endoderm, emigrate out into the mesentery at around E9.5, and eventually colonize the genital ridges at around E10.5 [2] . Then, they initiate sexually dimorphic development into either oocytes or spermatozoa, depending on the sex of the embryos [3] [4] [5] [6] [7] .
Recent studies have shown that PGCs establish key attributes of the germline, as reflected by the mechanism of PGC specification and survival/proliferation [1] , the mechanism regulating their potential pluripotency and genome-wide epigenetic reprogramming [8, 9] , and the mechanism underlying their choice to differentiate into oocytes or spermatozoa [4, 10] . These advances create an increasing demand for an experimental system with which to analyze the function of genes at desired time points during PGC development. For this purpose, a number of mouse strains for conditional gene targeting in PGCs (i.e., mouse strains expressing Cre recombinase in PGCs) have been generated, and these strains have been useful for the study of gene function in germ cell development [11] . However, with available strains, it remains difficult to explore the function of genes at precisely the right time and, specifically, in PGCs. For example, the Alpl (also known as Tnap [tissue nonspecific alkaline phosphatase])-Cre strain, the first strain aimed at germ cell-specific conditional gene targeting [12] , exhibits Cre-mediated recombination activity in PGCs after around E9.5 [11, 13] . However, Alpl is expressed relatively widely in embryos and adults [14] ; accordingly, the Alpl-Cre line exhibits widespread recombination in cell types other than germ cells [11] , making this line unsuitable for knockout studies of genes that may have a critical function in somatic cells as well. The Prdm1 (also known as Blimp1)-Cre transgenic line shows robust recombination activity in PGCs from their specification onward [15] . However, Prdm1 also exhibits expression in many other cell lineages, in which it plays a number of crucial roles (for review, see [16, 17] and references therein) and would potentially have a disadvantage similar to that of the AlplCre line. Other lines that have been generated more recently, such as the Ddx4 (also known as Mvh [mouse Vasa homologue])-Cre and the Nanos3-Cre lines, exhibit their recombination capacity only relatively late in germ cell development or at low efficiencies (Ddx4-Cre, ;E15; Nanos3-Cre, ;E7.75, and ;11%-25% at E12.5) [18] [19] [20] .
We therefore consider it essential to create a new line that allows specific, robust, and inducible gene recombination in PGCs. Toward this end, we generated transgenic strains expressing Cre recombinase flanked by mutated ligand-binding domains of the murine estrogen receptor (MER Cre MER [MCM] ) [21, 22] under the control of the Dppa3 gene (also known as Stella or Pgc7) [23, 24] . Dppa3 is a gene that specifically marks the establishment of PGCs at E7.25 and continues to be expressed strongly in embryonic germ cells until around E13.5 in females and around E15.5 in males [23, 24] . Flanking mutated ligand-binding domains of murine estrogen receptor (MER) sequences render the Cre activity dependent on chemicals structurally similar to ER agonists [21, 22] . With these lines, it would therefore be possible to elicit PGC-specific recombination at a desired time point from the time of PGC specification to the time of sex determination. Furthermore, Dppa3 reinitiates robust expression in primordial follicles in the postnatal ovary and continues to be expressed during the maturation of oocytes [24] . Dppa3 also shows zygotic expression from the 2-cell stage onward and continues to be expressed until around E4.5 in all cells of the blastocyst [24, 25] . Therefore, the Dppa3-MCM lines should function as specific deleters during oogenesis and preimplantation development as well.
In the present study, we show that the Dppa3-MCM transgenic strains exhibit highly specific and efficient Cremediated recombination activity during PGC development and oocyte growth as well as in preimplantation development in response to the administration of 4-hydroxytamoxifen (4-OHT), a ligand specific to MER. Thus, the single Dppa3-MCM transgenic strains should serve as useful lines to determine the function of genes both by loss-of-function and gain-of-function experiments at times of interest in the developmental cycle of the germ cell lineage.
MATERIALS AND METHODS

Construction of Venus and MCM Expression Vectors
The CMV promoter of the pEGFP-N1 vector (Clontech) was replaced with the CAG promoter [26] . The enhanced green fluorescent protein (EGFP) sequence was then replaced with Venus (a gift from Miyawaki, RIKEN Brain Science Institute, Wako City, Japan) [27] , MCM (a gift from M. Reth, Max Planck Institute of Immunobiology, Freiburg, Germany) [21] , 33FLAG-MCM (3F-MCM), and 33FLAG-MCM-PEST (3F-MCMP) sequences, respectively.
Culture and Transfection of Embryonic Stem Cells
The ECR5 Cre reporter embryonic stem cells (ESCs; EB3 [28, 29] with a single copy of the CAG-loxP-pacECFP-loxP-DsRed transgene) were maintained in Glasgow modified Eagle medium (Sigma) supplemented with 10% fetal bovine serum (Biological Industries), 2 mM L-glutamine (Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 0.1 mM 2-mercaptoethanol (Nacalai), and 1000 U/ml of leukemia inhibitory factor (Chemicon) on gelatinized culture dishes without feeder cells.
The ECR5 ESCs were grown on gelatinized 12-well dishes and were transfected with the pCAG-Venus and pCAG-MCM vectors (pCAG-MCM, pCAG-3F-MCM, and pCAG-3F-MCMP) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Twenty-four hours after transfection, the cells were washed with PBS and cultured in medium with 4-OHT (final concentration, 0.8 lM; H7904; Sigma). For the negative controls, 100% ethanol was added to the medium (final concentration, 0.01%). Seventytwo hours after transfection, the cells were washed with PBS and fixed in 4% paraformaldehyde (PFA) in PBS for 15 min at room temperature. The fixed cells were stained with 1 lg/ml of 4 0 ,6 0 -diamidino-2-phenylindole (DAPI; Invitrogen) in PBS-Tween 20 (PBST; 0.1%) for 30 min at room temperature. Images were captured by an IX71 fluorescent microscope equipped with a DP70 cold charge-coupled device camera (Olympus). Recombination efficiencies were determined by calculating the ratio of the number of cells doubly positive for DsRed and Venus to the number of cells positive for Venus.
Maintenance of the Mice and the Generation of Dppa3-MCMP and Dppa3-MCM Transgenic Strains
All animals were treated with appropriate care according to the ethics guidelines of RIKEN and Kyoto University. The R26R-EYFP [30] , Prdm1-Cre [15] , and Alpl-Cre [12] strains were kindly provided by F. Costantini (Columbia University, New York, NY), M. Nussenzweig (Rockefeller University, New York, NY), and A. Nagy (Mount Sinai Hospital, Toronto, ON, Canada), respectively. The R26R-EYFP strain was maintained on a C57BL/6:DBA ¼ 1:1 background (i.e., by intercrosses of B6DBA littermates). The other strains were maintained on a C57BL/6 background.
The bacterial artificial chromosome (BAC) bearing the Dppa3 genomic locus of the C57BL/6 strain was purchased from BACPAC Resources Center (Children's Hospital Oakland Research Institute). For the construction of the Dppa3-MCMP and Dppa3-MCM (Dppa3-MCM(P)) BAC transgenes, the 3F-MCMP or 3F-MCM sequence including the SV40 polyadenylation sequence was recombined after the initial in-frame ATG of exon 2 of the Dppa3 gene by Red/ET recombination (Gene Bridges) according to the manufacturer's instructions. With an additional two rounds of Red/ET recombination, genes upstream (Gdf3, Apobec1, Aicda, and Mfap5) and genes downstream (Gm8460, Gm10224, Nanog, and Slc2a3) of the Dppa3 gene were removed, and AscI recognition sites were added at both ends of the genomic locus around the Dppa3 gene. Consequently, the resultant BAC contained an approximately 34-kb sequence around the Dppa3 gene (chromosome 6: 122560090-122594281) (see Fig. 1B ). The final BAC construct was verified by restriction enzyme digestion and DNA sequencing.
The BAC was digested with AscI overnight. After heat inactivation of the enzyme, the buffer was exchanged for injection buffer (10 mM Tris-HCl [pH 7.5], 0.1 mM ethylenediaminetetra-acetic acid, and 100 mM NaCl) by gel filtration using a Sepharose CL-4B column (GE Healthcare) [31] . The Dppa3-MCMP or Dppa3-MCM construct was then injected into the pronuclei of B6DBA F 2 zygotes to generate transgenic mice, which were genotyped by PCR using the following primers: forward, 5 0 -CATACAGGCTGCATCGGTAAC-3 0 ; reverse, 5 0 -CTTGTCATCGTCATCCTTGTAATCGATG-3 0 ; and internal control reverse, 5 0 -TCTGGTTGTAGGACGTCTGAAACAG-3 0 . The band sizes of the PCR products were 280 bp (the transgene) and 200 bp (the internal control).
The genomic DNA of the transgenic mice was digested by EcoRI, and the copy numbers of the transgenes were determined by Southern blot analysis. As the probe, a portion of the intronic sequence between exon 1 and exon 2 of Dppa3 was amplified by PCR using the forward primer 5 0 -AGGGGAGCC CAAGATAGGCTGAG-3 0 and the reverse primer 5 0 -GTTGGGAAAC CAGCTCTCTCCGTTTG-3 0 . The band derived from the transgenes was approximately 3.5 kb longer than the band from the endogenous Dppa3 locus. The ratio of the signal intensity as determined by densitometry of the transgene band to that of the endogenous band (two copies) was calculated, and the transgene copy numbers were estimated. The selected Dppa3-MCM(P) lines are maintained on a C57BL/6 genetic background.
Administration of 4-OHT and Isolation of Transgenic Embryos
Female R26R-EYFP homozygous mice were mated with male Dppa3-MCMP, Dppa3-MCM, Prdm1-Cre, or Alpl-Cre mice, and noon on the day when the vaginal plugs of mated females were identified was recorded as E0.5. The female mice were killed at the designated stages to recover embryos.
The 4-OHT (H6278; Sigma) was dissolved in sunflower oil (final concentration, 5 mg/ml; S5007; Sigma) by sonication for 20-30 min. We assessed the toxicity of 4-OHT administrations to pregnant mice of various genetic backgrounds by injecting 4-OHT at different doses on Day 9.5 of pregnancy and evaluating the number of live embryos at E12.5 among total embryos.
For the recombination in postimplantation embryos, 5 mg of 4-OHT were injected intraperitoneally into the pregnant female mice between E7.0 and E11.5, and the embryos were isolated in PBS at E12.5. For recombination in postnatal ovaries, 3 mg of 4-OHT were injected intraperitoneally into the female R26R-EYFP;Dppa3-MCM(P) mice at 4 wk after birth, and the ovaries were isolated in PBS 4 days after the 4-OHT injection. When analyzing the recombination in preimplantation embryos, 4-OHT (H7904) was dissolved in dimethyl sulfoxide (Dojindo) at a concentration of 15.5, 31, or 62 lg/ml (40, 80, or 160 lM, respectively). Using M2 medium, the 2-cell embryos bearing the transgenes were flushed out from the oviducts of the females at E1.5, and the embryos were cultured overnight in the KSOM medium. The subsequently developed 4-to 8-cell embryos were treated with 4-OHT (final concentration, 0, 0.4, 0.8, or 1.6 lM) in KSOM for 24 h and then washed out by the KSOM. For immunostaining, the embryos were cultured in KSOM for an additional 24 h. For embryonic transfer, the embryos were transferred to a pseudopregnant ICR female at E2.5 and analyzed at E18.5.
Immunohistochemistry
All of the experiments in the immunohistochemistry assay were performed at room temperature unless otherwise indicated. Images were captured by confocal microscopy (LSM 510 META [Zeiss] or FV1000 [Olympus]).
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For the whole-mount immunostaining of blastocysts at E4.5, the embryos were fixed in 2% paraformaldehyde in PBS with 0.1% polyvinyl alcohol (PBS-PVA) for 30 min and were treated with 0.2% Triton X-100 in PBS-PVA for 15 min. The embryos were washed twice in PBS-PVA and incubated with a rat anti-green fluorescent protein (GFP) antibody (1:100; Nacalai) in PBS-PVA overnight at 48C. The embryos were washed twice in PBS-PVA, incubated with a secondary antibody (1:500, Alexa Fluor 488 goat anti-rat immunoglobulin G [IgG]; Invitrogen) in PBS-PVA for 1 h, incubated in 1 lg/ml of DAPI in PBS-PVA for 30 min, washed twice with PBS-PVA, and mounted in Vectashield mounting medium (Vector Laboratories) for microscopy.
For the immunostaining of cryosections, genital ridges at E12.5 were fixed in 4% paraformaldehyde in PBS for 2 h at 48C, and ovaries at 4 wk after birth were fixed in 2% paraformaldehyde in PBS for 3 h at 48C. Tissues were immersed successively in 10% and 30% sucrose in PBS, embedded in OCT compound (Sakura), frozen, and sectioned (thickness: genital ridges, 10 lm; ovaries, 16 lm) at À208C. Dried sections were washed three times in PBS and blocked with 10% normal goat serum (Vector Laboratories) in PBST (0.2%) for 15 min. The primary antibodies were rat anti-GFP (1:500; Nacalai) and rabbit anti-DDX4 (1:200, ab13840; Abcam), which were diluted in 5% normal goat serum in PBST and incubated with the sections for 2 h. The sections were washed three times with PBS and incubated with secondary antibodies (1:500, Alexa Fluor 488 goat anti-rat IgG and Alexa Fluor 568 goat anti-rabbit IgG; Invitrogen) in 5% normal goat serum in PBST for 1 h along with 1 lg/ml of DAPI. The sections were washed three times in PBS and were mounted in Vectashield mounting medium (Vector Laboratories) for microscopy.
RESULTS
Generation of Dppa3-MCM Transgenic Mice
Dppa3 is expressed at very high levels in preimplantation embryos, PGCs, and oocytes [23, 24] . Therefore, a transgene product expressed under the control of the regulatory elements of Dppa3 may persist for a relatively long time even after its mRNA expression has ceased. To realize the tight control of transgene-induced, drug-dependent Cre activity, we consider it potentially beneficial to provide a protein degradation sequence to MCM. We therefore decided to generate two different transgenic lines: one expressing MCM with a sequence rich in proline, glutamic acid, serine, and threonine (the PEST sequence; a degradation signal of the ubiquitin-proteasome system [32] ) and the other expressing MCM without a degradation sequence. We also decided to provide an epitope tag (33FLAG) to both constructs.
To confirm the recombinase activity of MCM with or without the PEST sequence or the epitope tag, we transfected the ECR5 ESCs with plasmids expressing MCM with or without these additional sequences and Venus under the control of the CAG promoter. Although ECR5 normally expresses enhanced cyan fluorescent protein (ECFP), on Cremediated excision of the ECFP sequence it in turn expresses DsRed [28, 29] (see Materials and Methods) (Fig. 1Aa) . Therefore, by measuring the number of DsRed-positive cells among the Venus-positive cells, the recombination frequency achieved with different MCM constructs can be estimated. The ECR5 cells predominantly expressed ECFP when MCM was not used for transfection (not shown). On transfection with as little as 10 ng of the plasmids expressing the parental MCM, the ECR5 showed a high percentage of recombination (;70%) when 4-OHT (0.8 lM) was administered (Fig. 1 , Ab and Ac). Transfection with increasing amounts of MCM resulted in as high as 90% recombination upon 4-OHT administration (Fig.  1Ac) . Notably, similar recombination frequencies were observed with MCM bearing 33FLAG at its N-terminus or MCM bearing the same epitope tag at its N-terminus and the PEST sequence at its C-terminus (Fig. 1Ad) . We found that transfection of increasing amounts of MCM leads to increasing frequencies of ligand-independent, nonspecific recombination, indicating that a proportion of MCM can sporadically enter the nucleus and exert recombination activity, especially when MCM is overexpressed (Fig. 1 , Ac and Ad).
We went on to generate two different transgene constructs: one expressing MCM with a 33FLAG at its N-terminus and the PEST sequence at its C terminus and the other expressing MCM with only the 33FLAG at its N-terminus, both under the control of the regulatory elements of the Dppa3 gene (Dppa3-MCMP and Dppa3-MCM, respectively). We inserted these two gene fragments after the initial in-frame ATG of exon 2 of the Dppa3 gene by BAC recombination [33] (Fig. 1B) . We purified the transgene fragments bearing approximately 16-kb upstream and approximately 18-kb downstream sequences, which are free from neighboring gene bodies, of the Dppa3 gene (chromosome 6: 122560090-122594281) (Fig. 1B) and injected these transgene fragments into the male pronuclei of the fertilized zygotes for the production of transgenic mice. We obtained 18 transgenic offspring for each transgene, with the integration of varying copy numbers of the transgenes (Fig. 1 , Ca and Cb). We examined the activity of the transgenes in male transgenic lines bearing high copy numbers for each construct: two lines with an estimated transgene copy number of eight for Dppa3-MCMP and two lines with an estimated transgene copy number of four for Dppa3-MCM. Because the two lines for each construct gave similar results, we present here the data from the representative line for each construct (line 9 for Dppa3-MCMP and line 3 for Dppa3-MCM, both maintained on a C57BL/6 genetic background). Other lines with low copy numbers did not exhibit efficient recombination activities (data not shown).
Recombination of a Reporter Gene During PGC Development
Before the evaluation of the recombination activity of the Dppa3-MCM(P) lines, we assessed the toxicity of 4-OHT administration to embryonic development. Toward this end, we administered varying doses of 4-OHT (1.25, 2.5, or 5 mg/ mouse) to pregnant females bearing embryos on different genetic backgroun ds (/ B 63? B6 , / B63? BDF1, /BDF13?B6, or /BDF13?BDF1) at E9.5 and examined the number of healthy embryos at E12.5. As shown in Supplemental Table S1 (all Supplemental Data are available online at www.biolreprod.org), administration of 4-OHT at doses up to 2.5 mg/pregnant mouse did not lead to apparent abnormalities of the embryos as judged by their overall morphology, size, and heart beat. When the mice were administered 5 mg of 4-OHT, which is a dose used for in vivo activation of MCM [22] , we observed some abnormal/ dead embryos in three of the backgrounds we tested, and the survival rates of the embryos were approximately 70% on these backgrounds (Supplemental Table S1 ). Embryos of BDF1 females mated with B6 males did not show such abnormalities (Supplemental Table S1 ). These findings indicate that embryos generally tolerate 4-OHT administration up to 5 mg/pregnant mouse, although a minority of them (;30%) show abnormalities with the high dosage of 4-OHT (5 mg/pregnant mouse).
We then went on to evaluate the recombination activity of the transgenes during PGC development. For this purpose, we crossed the male Dppa3-MCM(P) lines with the female transgenic reporter strains homozygously bearing the floxed pgk-Neo-poly(A) sequence followed by the enhanced yellow fluorescent protein (EYFP) gene homologously integrated into the constitutively active Rosa26 locus (R26R-EYFP; C57BL/ 6:DBA¼1:1 genetic background) [30] (Fig. 2Aa) . It is expected that on administration of 4-OHT, the MCM(P) protein expressed in PGCs translocates to the nucleus and excises out the floxed sequence, resulting in the expression of EYFP under the control of the Rosa26 promoter.
We administered 4-OHT (5 mg/female) intraperitoneally to the pregnant reporter females mated with the Dppa3-MCMP males on E7.0, E8.5, E9.5, and E11.5, and we examined the recombination events in embryos isolated at E12.5 (Fig. 2Ab) . As shown in Fig. 2B (and Table 1 ), no nonspecific recombination events were detected in embryos exposed to 4-OHT at any of the time points examined, indicating the high specificity of transgene expression. We did not observe any recombination in embryos that had not been exposed to 4-OHT (Fig. 2C) , demonstrating that MCMP depends strictly on 4-OHT administration for nuclear translocation and recombination activity. We detected recombination in a small proportion of cells in the genital ridges in embryos exposed to 4-OHT at 370 HIROTA ET AL. E7.0 (Fig. 2 , Ba and Bb). Embryos exposed to 4-OHT at E8.5 exhibited a higher proportion of recombination in cells in the genital ridges, and those exposed to the drug at E9.5 showed very high levels of recombination in cells in the genital ridges (Fig. 2 , Bc-Bf). We confirmed that the cells expressing the reporter were indeed PGCs by doubly staining the genital ridge sections with anti-DDX4 antibody and anti-EGFP antibody: All of the reporter-positive cells were positive for DDX4, a representative marker for PGCs in the genital ridges and subsequent germ cells [34, 35] (Fig. 2D and data not shown) . The recombination frequency in PGCs when 4-OHT was administrated at E9.5 reached approximately 80% (Table 1) . Embryos exposed to 4-OHT at E11.5 exhibited a similarly high rate of recombination to those exposed to the drug at E9.5, although the level of EYFP expression appears to have been low because of the short expression time (Fig. 2 , Bg-Bh, and Table 1 ). Administrations of lower doses of 4-OHT at any of these developmental stages resulted in lower recombination efficiencies (data not shown).
FIG. 2. Recombination in PGCs of
We evaluated the recombination activity of Dppa3-MCM strains in the same manner. That series yielded similar results regarding specific recombination in PGCs, although a somewhat lower efficiency was observed when 4-OHT was administrated at E9.5 (Fig. 2 , Bi-Bn). It is of note that one Dppa3-MCM embryo out of five transgenics from two litters, which were administered 4-OHT at E7.0, exhibited EYFP fluorescence in a wide range of tissues (Fig. 2 , Bk and Bl), indicating the nonspecific recombination in many embryonic tissues. We did not see this nonspecific recombination in Dppa3-MCMP embryos administered 4-OHT at E7.0 (seven transgenic embryos from two litters). The litter sizes of the R26R-EYFP females mated with the Dppa3-MCM(P) strains with 4-OHT administration (5 mg) were similar to those without 4-OHT administration (Supplemental Table S2 ).
To compare the specificity and sensitivity of Cre-mediated recombination of the Dppa3-MCM(P) strains to those of other available Cre lines with respect to recombination in PGCs, we evaluated the recombination activity of the Alpl-Cre [12] and Prdm1-Cre [15] strains, both maintained on a C57BL/6 genetic background, by crossing them with the same reporter mice. We isolated reporter embryos bearing the Alpl-Cre transgene at E12.5. As evident from the data shown in Figure 3 , Aa and Ab, the embryos showed widespread expression of the reporter 372 gene, indicating that Alpl-Cre indeed shows widespread activity in embryos. We isolated the genital ridges with attached mesonephros and found that recombination was active in the genital ridges of the cells as well as in the mesonephros (Fig. 3Ab) . We then created frozen sections of the genital ridges and doubly stained them for DDX4 and the reporter. The DDX4-positive PGCs were positive for the reporter at a very high percentage (;90%) (Table 1) ; however, numerous DDX4-negative cells were also clearly positive for the reporter (Fig. 3B) .
The reporter embryos crossed with the Prdm1-Cre mouse isolated at E12.5 exhibited reporter gene expression in regions such as around the branchial arch and posterior to the forelimb and hindlimb (Fig. 3Ac) . These regions are known to be positive for Prdm1 expression [36] [37] [38] . The isolated genital ridges with mesonephros revealed that the reporter was activated in cells in the genital ridges and in the müllerian ducts (Fig. 3Ad) . Immunofluorescence analyses of the frozen sections revealed that nearly all of the DDX4-positive cells were reporter-positive, indicating highly efficient recombination in the PGCs by the Prdm1-Cre transgene ( Fig. 3B and Table 1 ). However, we noted some recombination in the genital ridges of DDX4-negative cells (Fig. 3B ), which were presumably forming blood vessels positive for Prdm1 expression [36] [37] [38] .
Collectively, these findings demonstrate that the Dppa3-MCM(P) lines are the robust and highly specific deleters of the floxed sequence in PGCs and that their recombination activity is strictly dependent on the presence of 4-OHT. However, the recombination efficiency in PGCs of these lines may be slightly lower than that of the Alpl-Cre and Prdm1-Cre lines.
Recombination of a Reporter Gene During Oogenesis
We next examined the recombination activity of the Dppa3-MCM(P) lines in developing oocytes. To this end, we 374 administered 3 mg of 4-OHT to 4-wk-old female reporter mice bearing the Dppa3-MCM(P) transgenes, and we evaluated reporter gene expression 4 days later (Fig. 4A) . As shown in Fig. 4B , isolated ovaries from both the transgenic lines exhibited clear fluorescence indicative of specific recombination in developing oocytes.
To confirm this finding, we created frozen sections of the recombined ovaries and stained the sections for DDX4 and the reporter. As shown in Figure 4C , both the transgenes activated the expression of the reporter gene exclusively in DDX4-positive developing oocytes. No recombination was detected in somatic cells. We also did not detect any recombination in ovaries bearing the Dppa3-MCM(P) transgenes in the absence of 4-OHT administration (Fig. 4C and data not shown) . We then quantified the recombination efficiencies in oocytes at different developmental stages, and we found that the Dppa3-MCMP transgene activated recombination to levels exceeding 90% in the primordial follicles. In addition, gradually decreasing recombination efficiencies were observed in the primary follicles (78.4%), secondary follicles (65.6%), and antral follicles (59.5%) ( Table 2 ). In contrast, the Dppa3-MCM transgene elicited nearly 100% recombination in the oocytes at all developmental stages (Table 2 ). These findings demonstrate that the Dppa3-MCM(P) lines are powerful and specific deleters of the floxed sequences in oocytes at any developmental stage provided that 4-OHT has been administered.
Recombination of a Reporter Gene During Preimplantation Development
We next determined the recombination activity of the Dppa3-MCMP line during preimplantation development. Thus, we crossed the reporter females with the Dppa3-MCMP line, flushed out the embryos at E1.5 from the oviducts, cultured the embryos in vitro, added 4-OHT (0, 0.4, 0.8, or 1.6 lM) at E2.5 to the culture medium, washed out the drug at E3.5, and evaluated the recombination events at E4.5 (Fig. 5A) .
As shown in Figure 5B and Table 3 , most of the blastomeres or cells of in vitro-cultured embryos did not exhibit drugindependent recombination, despite the fact that Dppa3 shows very high expression during preimplantation development [24, 25, 39] , indicating an efficient sequestration of the MCMP protein in the cytoplasm. We observed recombination in some cells of one embryo, which looked somewhat abnormal (Fig.  5C ). In contrast, when 4-OHT was added to the culture medium, we observed highly efficient recombination in blastocyst-stage embryos (Fig. 5B and Table 3 ). We scanned the entire set of embryos at E4.5 by confocal microscopy and evaluated recombination efficiency; we found that more than 90% of the cells in the blastocyst-stage embryos (i.e., both the cells of the inner cell mass as well as trophectoderm cells) exhibited recombination (Fig. 5B and Table 3 ). Thus, the Dppa3-MCMP transgene exhibits robust recombination activity in all cells in preimplantation embryos.
To examine whether the Dppa3-MCMP line can be used as a deleter of floxed conditional alleles in whole tissues, we mated the reporter females with Dppa3-MCMP males, obtained the embryos at E1.5, cultured them in vitro, administrated 0.8 lM of 4-OHT at E2.5, washed out the 4-OHT, and transferred the blastocysts at E3.5 to foster mothers. We transferred 66 embryos and obtained 13 live pups from among 33 embryos with implantation. Among these pups, two were Dppa3-MCMP transgenic, and both showed uniform expression of the reporter throughout their bodies ( Fig. 5Da and Table 4 ). We confirmed that essentially all of the cells in the tissues of the three germ layers (e.g., brain, eyeball, heart, kidney, testis, thymus, lung, liver, stomach, and intestine) were positive for recombination of the reporter gene (Fig. 5Db) , which was in good agreement with the finding that nearly all of the cells in the inner cell mass of the blastocysts showed transgene recombination. The Dppa3-MCMP line may therefore also be useful as a deleter of floxed alleles in whole tissues.
DISCUSSION
In the present study, we have shown the generation of transgenic strains (i.e., Dppa3-MCM(P) lines) that allow the drug-inducible recombination of floxed sequences during the developmental cycle of germ cells. These Dppa3-MCM(P) lines exhibited the 4-OHT-dependent recombination of a floxed allele specifically in PGCs as early as E7.0 and highly robustly after E9.5 (Fig. 2) . These data are consistent with the observations that Dppa3 expression in PGCs begins at around E7.0 and becomes gradually higher [23, 24] and that the expression of transgenes driven by the Dppa3 regulatory elements becomes detectable starting at around E7.5-E8.5 [38, 39] .
One Dppa3-MCM transgenic embryo (one of five transgenic embryos from two litters) treated with 4-OHT at E7.0 exhibited nonspecific recombination in a wide range of tissues (Fig. 2 , Bk and Bl). This indicates the persistence of the MCM protein throughout the embryo as late as E7.0. Endogenous DPPA3 is expressed in all of the cells in the blastocysts at E3.5 but becomes undetectable after E4.5 [24] . However, in a transgenic reporter strain expressing ECFP under the control of the Dppa3 regulatory elements, we detected ECFP expression as late as E5.5 [38] . It therefore appears that in rare cases, the MCM protein driven by the Dppa3 regulatory elements persists in many of the embryonic cells and recombines the floxed sequence on 4-OHT administration as late as E7.0. In contrast, we did not observe such nonspecific recombination in Dppa3-MCMP transgenic embryos treated with 4-OHT at E7.0 (zero of seven transgenic embryos from two litters). This indicates that the PEST sequence in MCMP indeed functions to facilitate the degradation of MCMP protein in embryonic cells.
It is also of note that when 4-OHT was administered at E11.5, highly efficient and specific recombination in PGCs by the Dppa3-MCMP transgene was already evident at E12.5 (Fig. 2). Considering that it takes approximately 12 h for the expressed fluorescent protein to become detectable [40] , this finding indicates that the recombination induced by the administration of 4-OHT occurs quickly (;12 h). It would therefore be possible with the Dppa3-MCM(P) lines to regulate the activity of genes in PGCs using very precise timing. Because PGCs undergo critical events such as genome-wide epigenetic reprogramming and sex determination when they colonize the genital ridges after around E10.5, the Dppa3-MCM(P) lines should serve as useful material to analyze the molecular mechanisms underlying these events. We demonstrated in the present study that although the AlplCre line recombined the floxed sequence in PGCs at a high ratio at E12.5, at the same time it excised the floxed sequence in a broad range of somatic cells (Fig. 3) . This would render it difficult to use the Alpl-Cre line for the conditional knockout of genes whose function would be developmentally critical in somatic tissues, because the deletion of such genes may lead to embryonic lethality or severe phenotypes in somatic cells, which would complicate the interpretation of the phenotypes seen in the PGCs. In fact, several reports have documented such complexities associated with the use of the Alpl-Cre line [41, 42] . The Prdm1-Cre line exhibited clear and efficient recombination in PGCs at E7.75 [15] and E12.5 ( Fig. 3) , but recombination was also seen in somatic tissues in which Prdm1 is expressed (Fig. 3) . Therefore, although the Prdm1-Cre line is a powerful deleter of the floxed sequences in PGCs starting at a very early stage of development, it is also important to note that it elicits recombination in distinct somatic populations. In particular, the Prdm1-Cre line would induce recombination in the hindgut endoderm through which PGCs migrate. It would therefore be important to carefully consider use of this line for the evaluation of PGC-specific functions of genes that are also expressed in the hindgut endoderm. Additionally, the existing Ddx4-Cre line exhibits recombination activity only relatively late in germ cell development (;E15) and shows recombination in whole tissues at a relatively high rate (;20%) [18, 19] . Furthermore, the Nanos3-Cre line shows early recombination in PGCs (;E7.75); however, its recombination activity in PGCs is low (;11%-25% at E12.5) and it exhibits nearly 100% recombination in male gonocytes [20] . It also exhibits recombination in whole tissues at a relatively high rate (;12%) [20] . Therefore, it may be the case that neither the Ddx4-Cre nor the Nanos3-Cre line is particularly useful for analysis of the molecular events in PGCs. Compared to these lines, the Dppa3-MCM(P) lines exhibit unambiguously exclusive recombination in PGCs. Moreover, with the Dppa3-MCM(P) lines, the onset of recombination can be controlled by the timing of 4-OHT administration. It has been reported that 4-OHT is metabolized into inactive compounds within approximately 6 h after administration [43] . This suggests that the recombination induced by 4-OHT administration occurs rather quickly and persists for less than 6 h. Nonetheless, the Dppa3-MCM(P) lines exhibited nearly 80% recombination efficiency in PGCs at E12.5 by 4-OHT injection at E9.5 or E11.5. Thus, compared to what can be achieved with the Alpl-Cre and Prdm1-Cre lines, the Dppa3-MCM(P) lines provide superior control of gene activity in PGC development.
Consistent with the expression of Dppa3, the Dppa3-MCM(P) lines allowed specific and efficient 4-OHT-dependent recombination in developing oocytes at all developmental stages (Fig. 4 and Table 2 ). We note, however, that the Dppa3-MCM line exhibited recombination activity superior to that of the Dppa3-MCMP line in oocytes at all developmental stages, especially later stages. We do not know the exact reason for this difference, in part because other lines with relatively low transgene copy numbers exhibited generally lower recombination efficiencies (data not shown). It may be the case that the oocytes have a higher degradation activity toward the proteins bearing the PEST sequence. In particular, because transcription from the genome is generally shut off in the fully grown oocytes [44] , the recombination activity of the Dppa3-MCM(P) strains should depend on the translated and accumulated MCM(P). In this situation, MCMP should degrade faster than MCM; thus, the Dppa3-MCMP line would exhibit a lower recombination activity.
We also showed that the Dppa3-MCMP strain allowed specific and efficient 4-OHT-dependent recombination in preimplantation embryos. We did not observe any drugindependent recombination in PGC and oocyte development by the Dppa3-MCM(P) transgenes, which indicated the highly efficient sequestration of the Cre recombinase by flanking MER sequences. However, we did observe sporadic recombination in the absence of 4-OHT in cultured preimplantation embryos. This finding may have been reflected the very high expression of the Dppa3 gene in preimplantation development [24, 25, 39] , or it may have reflected certain abnormalities associated with the in vitro culture of the embryos. We consider the latter as the more likely explanation for two reasons. First, one of the embryos that exhibited recombination without drug treatment appeared as if it had developed in a somewhat abnormal manner (Fig. 5C) . Second, and more importantly, we did not observe any 4-OHT-independent expression of the reporter in more than 60 embryos or 4-wkold mice bearing the Dppa3-MCMP or Dppa3-MCM transgene that had undergone in vivo preimplantation development, and our analysis was focused on recombination in PGCs or oocytes (see Figs. 2 and 4) .
Evidence has been accumulating that to realize totipotency, the germ cell lineage undergoes elaborate regulation of its genome as well as of epigenome function during the developmental cycle [1, 8] . Elucidating the molecular mechanisms underlying germ cell development is thus of fundamental importance in the fields of developmental biology, epigenetics, and reproductive biology as well as in regenerative medicine. The Dppa3-MCM(P) lines that allow highly specific, efficient, and temporally precise control of gene activity in the germ cell lineage should serve as critical materials for gaining a better understanding of gene function contributing to the design principles of the germ cell lineage.
